Unibest
← Back to patent-cliff list

Maralixibat Chloride

Tier C — Watch / trade

Maralixibat Chloride

Pfizer Inc.
Originator
2021
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:IBAT

Brand:LIVMARLI

Indications (approved):Pruritus, 进行性家族性肝内胆汁淤积症, Alagille综合征

Regional status

US
Approved
2021-09-29
EU
Approved
2022-12-09
China
Approved
2023-05-29
Japan
Phase III
2023-01-10

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 15 · Total yield /
Lopix-001596-75-8Lopix-00224765-57-9Lopix-0033670-91-5Lopix-004197378-20-4Lopix-005228113-57-3Lopix-006228113-59-5Lopix-007228113-60-8Lopix-008228113-61-9Lopix-009228113-62-0Lopix-010228113-63-1Lopix-011197373-42-5Lopix-012228113-65-3Lopix-013623-25-6Lopix-014289038-78-4Lopix-015371-41-5Lopix-016824-94-2Lopix-0171426-54-6Lopix-01816420-13-6Lopix-019228113-58-4API · Maralixibat Chloride
CodeCAS No.Intermediate
Lopix-001596-75-8diethyl 2,2-dibutylmalonate
Lopix-00224765-57-92,2-dibutylpropane-1,3-diol
Lopix-0033670-91-51,3,2-Dioxathiane, 5,5-dibutyl-, 2-oxide
Lopix-004197378-20-41,3,2-Dioxathiane, 5,5-dibutyl-, 2,2-dioxide
Lopix-005228113-57-34-fluoro-2-(4-methoxybenzyl)benzenethiol
Lopix-006228113-59-52-butyl-2-((4-fluoro-2-(4-methoxybenzyl)phenylthio)methyl)hexan-1-ol
Lopix-007228113-60-82-butyl-2-((4-fluoro-2-(4-methoxybenzyl)phenylsulfinyl)methyl)hexan-1-ol
Lopix-008228113-61-92-butyl-2-((4-fluoro-2-(4-methoxybenzyl)phenylsulfinyl)methyl)hexanal
Lopix-009228113-62-01-Benzothiepin-4-ol, 3,3-dibutyl-7-fluoro-2,3,4,5-tetrahydro-5-(4-methoxyphenyl)-, 1-oxide, (4R,5R)
Lopix-010228113-63-11-Benzothiepin-4-ol, 3,3-dibutyl-7-fluoro-2,3,4,5-tetrahydro-5-(4-methoxyphenyl)-, 1,1-dioxide, (4R,5R)
Lopix-011197373-42-51-Benzothiepin-4-ol, 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-methoxyphenyl)-, 1,1-dioxide, (4R,5R)-rel
Lopix-012228113-65-31-Benzothiepin-4-ol, 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-hydroxyphenyl)-, 1,1-dioxide, (4R,5R)
Lopix-013623-25-61,4-bis(chloromethyl)benzene
Lopix-014289038-78-41-Benzothiepin-4-ol, 3,3-dibutyl-5-[4-[[4-(chloromethyl)phenyl]methoxy]phenyl]-7-(dimethylamino)-2,3,4,5-tetrahydro-, 1,1-dioxide, (4R,5R)
Lopix-015371-41-54-fluorophenol
Lopix-016824-94-21-(chloromethyl)-4-methoxybenzene
Lopix-0171426-54-64-fluoro-2-(4-methoxybenzyl)phenol
Lopix-01816420-13-6dimethylcarbamothioic chloride
Lopix-019228113-58-4O-4-fluoro-2-(4-methoxybenzyl)phenyl dimethylcarbamothioate
OptimisedRoute 2Steps 12 · Total yield /
Lopix-011197373-42-5Lopix-012228113-65-3Lopix-013623-25-6Lopix-014289038-78-4Lopix-0202516-95-2Lopix-021100-66-3Lopix-02270132-87-5Lopix-023197378-07-7Lopix-024197378-29-3Lopix-025197378-31-7Lopix-026—Lopix-027—Lopix-028—Lopix-029—API · Maralixibat Chloride
CodeCAS No.Intermediate
Lopix-011197373-42-51-Benzothiepin-4-ol, 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-methoxyphenyl)-, 1,1-dioxide, (4R,5R)-rel
Lopix-012228113-65-31-Benzothiepin-4-ol, 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-hydroxyphenyl)-, 1,1-dioxide, (4R,5R)
Lopix-013623-25-61,4-bis(chloromethyl)benzene
Lopix-014289038-78-41-Benzothiepin-4-ol, 3,3-dibutyl-5-[4-[[4-(chloromethyl)phenyl]methoxy]phenyl]-7-(dimethylamino)-2,3,4,5-tetrahydro-, 1,1-dioxide, (4R,5R)
Lopix-0202516-95-25-chloro-2-nitrobenzoic acid
Lopix-021100-66-3Availableanisole
Lopix-02270132-87-5(2-chloro-5-nitrophenyl)(4-methoxyphenyl)methanone
Lopix-023197378-07-71-chloro-2-(4-methoxybenzyl)-4-nitrobenzene
Lopix-024197378-29-32-butyl-2-((2-(4-methoxybenzyl)-4-nitrophenylthio)methyl)hexanal
Lopix-025197378-31-72-butyl-2-((2-(4-methoxybenzyl)-4-nitrophenylsulfonyl)methyl)hexanal
Lopix-026-2-((4-amino-2-(4-methoxybenzyl)phenylsulfonyl)methyl)-2-butylhexanal
Lopix-027-benzyl 4-(2-butyl-2-formylhexylsulfonyl)-3-(4-methoxybenzyl)phenylcarbamate
Lopix-028--
Lopix-029--

Frequently asked questions

What are the approved indications of Maralixibat Chloride?

Approved indications include: Pruritus, 进行性家族性肝内胆汁淤积症, Alagille综合征.

When does the Maralixibat Chloride patent expire?

No public expiry year is available for Maralixibat Chloride yet; this page updates once verified.

How many synthesis routes are recorded for Maralixibat Chloride?

2 synthesis routes are recorded; the shortest is 12 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Maralixibat Chloride intermediates?

1 intermediate CAS of Maralixibat Chloride are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Maralixibat Chloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29